Evidence map›Paper›PMID 37077558›Full record

ArticleERJ open research2023

ERS International Congress 2022: highlights from the Basic and Translational Science Assembly.

Sara Cuevas Ocaña, Natalia El-Merhie, Merian E Kuipers, Mareike Lehmann, Sara Rolandsson Enes, Carola Voss, Lareb S N Dean, Matthew Loxham, Agnes W Boots, Suzanne M Cloonan and 9 more

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Wildfire and asthma - The prospective interventions.The World Allergy Organization journal · 2025
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 7 countries.

Sara Cuevas OcañaNottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
Natalia El-MerhieInstitute for Lung Health, Faculty of Medicine, Justus Liebig University, Member of the German Center for Lung Research (DZL), Giessen, Germany.ORCID https://orcid.org/0000-0002-0682-4022
Merian E KuipersDepartment of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.ORCID https://orcid.org/0000-0002-9771-9825
Mareike LehmannInstitute of Lung Health and Immunity, Comprehensive Pneumology Center, Helmholtz Munich, Member of the DZL, Munich, Germany.ORCID https://orcid.org/0000-0002-8601-8206
Sara Rolandsson EnesFaculty of Medicine, Department of Experimental Medical Science, Unit of Lung Biology, Lund University, Lund, Sweden.
Carola VossInstitute of Lung Health and Immunity, Comprehensive Pneumology Center, Helmholtz Munich, Member of the DZL, Munich, Germany.
Lareb S N DeanFaculty of Medicine, School of Clinical and Experimental Sciences, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0002-8703-9236
Matthew LoxhamFaculty of Medicine, School of Clinical and Experimental Sciences, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0001-6459-538X
Agnes W BootsDepartment of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands.
Suzanne M CloonanSchool of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Catherine M GreeneDepartment of Clinical Microbiology, RCSI University of Health Sciences, Dublin, Ireland.ORCID https://orcid.org/0000-0003-2549-2569
Irene H HeijinkDepartments of Pathology, and Medical Biology and Pulmonology, University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, The Netherlands.
Audrey JoannesUniversity of Rennes, CHU Rennes, Inserm, EHESP, Research Institute for Environmental and Occupational Health-UMR_S 1085, Rennes, France.ORCID https://orcid.org/0000-0001-7658-0695
Arnaud A MailleuxUniversité Paris Cité, Inserm, Physiopathologie et épidémiologie des maladies respiratoires, Paris, France.ORCID https://orcid.org/0000-0003-4191-1778
Nahal MansouriSwiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Niki L ReynaertDepartment of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Anne M van der DoesDepartment of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
Darcy E WagnerLung Bioengineering and Regeneration, Department of Experimental Medical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0003-3794-1309
Niki UbagsDivision of Pulmonary Medicine, Department of Medicine, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-0177-4134
Helmholtz Zentrum München · DEInserm · FRLeiden University Medical Center · NLLund University · SENIHR Southampton Biomedical Research Centre · GBÉcole Polytechnique Fédérale de Lausanne · CHGerman Center for Lung Research · DEMaastricht University · NLMaastricht University Medical Centre · NLTrinity College Dublin · IEUniversity Medical Center Groningen · NLUniversity of Lausanne · CHUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this review, the Basic and Translational Science Assembly of the European Respiratory Society provides an overview of the 2022 International Congress highlights. We discuss the consequences of respiratory events from birth until old age regarding climate change related alterations in air quality due to pollution caused by increased ozone, pollen, wildfires and fuel combustion as well as the increasing presence of microplastic and microfibres. Early life events such as the effect of hyperoxia in the context of bronchopulmonary dysplasia and crucial effects of the intrauterine environment in the context of pre-eclampsia were discussed. The Human Lung Cell Atlas (HLCA) was put forward as a new point of reference for healthy human lungs. The combination of single-cell RNA sequencing and spatial data in the HLCA has enabled the discovery of new cell types/states and niches, and served as a platform that facilitates further investigation of mechanistic perturbations. The role of cell death modalities in regulating the onset and progression of chronic lung diseases and its potential as a therapeutic target was also discussed. Translational studies identified novel therapeutic targets and immunoregulatory mechanisms in asthma. Lastly, it was highlighted that the choice of regenerative therapy depends on disease severity, ranging from transplantation to cell therapies and regenerative pharmacology.

Identifiers

PMID37077558
PMCPMC10107060
OpenAlexW4318070511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.